Nivolumab vs Oseltamivir

## Nivolumab vs Oseltamivir: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Oseltamivir**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Oseltamivir**: Neuraminidase inhibitor preventing viral release from host cells.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Oseltamivir — 6-10 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Oseltamivir — C16H28N2O4.

**Molecular Weight**: Nivolumab — N/A; Oseltamivir — 312.4050 g/mol.

**Type**: Nivolumab — Antibody; Oseltamivir — Small molecule.